TRAF3 and glioblastoma: To investigate the effect of TRAF3 overexpression on anti–PD-L1 immunotherapy, we established an orthotopic xenograft GBM model using mouse CT-2A and GL261 GBM cells, respectively (Figure 8G and Supplemental Figure 8,G and H).